Sign In
Buy PTCT
$68.68
+0.450 (+0.660%)
At Close: Jun 03, 2026
Here's Why PTC Therapeutics (PTCT) is Poised for a Turnaround After Losing 23.4% in 4 Weeks
11:19am, Monday, 31'st Oct 2022
PTC Therapeutics (PTCT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings es
PTC Therapeutics, Inc. (PTCT) Q3 2022 Earnings Call Transcript
10:15pm, Thursday, 27'th Oct 2022
PTC Therapeutics, Inc. (NASDAQ:PTCT ) Q3 2022 Results Conference Call October 27, 2022 4:30 PM ET Company Participants Kylie O'Keefe - SVP, Head of Global Commercial and Corporate Strategy Stuart Pelt
PTC Therapeutics shares fall 10% after announcing pause in U.S. enrollment for a clinical trial
09:47am, Wednesday, 19'th Oct 2022
Shares of PTC Therapeutics Inc. PTCT, -10.87% were down 10.1% in trading on Wednesday morning, the day after the company said enrollment in a Phase 2 clinical trial for its Huntington's disease treatm
PTC Therapeutics, Inc. (PTCT) CEO Stuart Peltz On Q2 2022 Results - Earnings Call Transcript
08:02am, Sunday, 07'th Aug 2022
PTC Therapeutics (NASDAQ:PTCT ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Kylie O'Keefe - Senior Vice President, Head of Global Commercial & Corporate Strategy St
PTC Therapeutics (PTCT) Reports Q2 Loss, Tops Revenue Estimates
08:18pm, Thursday, 04'th Aug 2022
PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -27.54% and 13.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
PTC Therapeutics, Inc. (PTCT) CEO Stuart Peltz on Q1 2022 Results - Earnings Call Transcript
12:23am, Wednesday, 04'th May 2022
Start Time: 16:30 January 1, 0000 5:36 PM ET PTC Therapeutics, Inc. (NASDAQ:PTCT ) Q1 2022 Earnings Conference Call May 03, 2022, 16:30 PM ET Company Participants Stuart Peltz - Founder and CEO Matthe
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
09:45pm, Tuesday, 03'rd May 2022 Zacks Investment Research
PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -14.84% and 2.41%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Will PTC Therapeutics (PTCT) Report Negative Earnings Next Week? What You Should Know
07:01pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
PTC Therapeutics (PTCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PTC Therapeutics: One Of The Leaders In The Treatment Of Rare Diseases
07:13am, Monday, 11'th Apr 2022
PTC Therapeutics has been cooperating with Roche since 2011.
PTC Therapeutics (PTCT) Soars 11.1%: Is Further Upside Left in the Stock?
11:32am, Monday, 04'th Apr 2022 Zacks Investment Research
PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength dow
PTC Therapeutics (PTCT) Soars 11.1%: Is Further Upside Left in the Stock?
09:02am, Monday, 04'th Apr 2022
PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength dow
United Therapeutics (UTHR) Moves 3.1% Higher: Will This Strength Last?
09:18am, Monday, 14'th Mar 2022 Zacks Investment Research
United Therapeutics (UTHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near t
PTC Therapeutics to Participate at Upcoming Investor Conferences
08:00am, Wednesday, 23'rd Feb 2022
SOUTH PLAINFIELD, N.J., Feb. 23, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences: Cowen Virtual 42
PTC Therapeutics, Inc. (PTCT) CEO Stuart Peltz on Q4 2021 Results - Earnings Call Transcript
05:51am, Wednesday, 23'rd Feb 2022 Seeking AlphaPTC Therapeutics, Inc. (PTCT) CEO Stuart Peltz on Q4 2021 Results - Earnings Call Transcript
12:51am, Wednesday, 23'rd Feb 2022
PTC Therapeutics, Inc. (PTCT) CEO Stuart Peltz on Q4 2021 Results - Earnings Call Transcript
